2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Current Neuropharmacology CURR NEUROPHARMACOL (此期刊被最新的JCR期刊SCIE收录) LetPub评分 7.4
50人评分
我要评分
声誉 8.8 影响力 6.3 速度 7.0 | |||||||||||||||||||||||||||||||||
期刊ISSN | 1570-159X | 微信扫码收藏此期刊 | ||||||||||||||||||||||||||||||||
E-ISSN | 1875-6190 | |||||||||||||||||||||||||||||||||
2023-2024最新影响因子 (数据来源于搜索引擎) | 4.8 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||||
实时影响因子 | 截止2024年10月29日:3.792 | |||||||||||||||||||||||||||||||||
2023-2024自引率 | 0.00%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||||
五年影响因子 | 7.1 | |||||||||||||||||||||||||||||||||
JCI期刊引文指标 | 0.85 | |||||||||||||||||||||||||||||||||
h-index | 58 | |||||||||||||||||||||||||||||||||
CiteScore ( 2024年最新版) |
| |||||||||||||||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||||||||||||||
期刊官方网站 | http://benthamscience.com/journal/index.php?journalID=cn | |||||||||||||||||||||||||||||||||
期刊投稿网址 | http://bsp-cms.eurekaselect.com/index.php/CN | |||||||||||||||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Current Neuropharmacology的语言要求,还能让Current Neuropharmacology编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Current Neuropharmacology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||||||||||
是否OA开放访问 | No | |||||||||||||||||||||||||||||||||
通讯方式 | BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR | |||||||||||||||||||||||||||||||||
出版商 | Bentham Science Publishers B.V. | |||||||||||||||||||||||||||||||||
涉及的研究方向 | 医学-神经科学 | |||||||||||||||||||||||||||||||||
出版国家或地区 | ENGLAND | |||||||||||||||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||||||||||||||
出版周期 | Quarterly | |||||||||||||||||||||||||||||||||
出版年份 | 2003 | |||||||||||||||||||||||||||||||||
年文章数 | 161点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||||
Gold OA文章占比 | 4.45% | |||||||||||||||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 26.09% | |||||||||||||||||||||||||||||||||
WOS期刊SCI分区 ( 2023-2024年最新版) | WOS分区等级:1区
| |||||||||||||||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2023年12月最新升级版) | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2022年12月升级版) |
| |||||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2021年12月旧的升级版) |
| |||||||||||||||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1570-159X%5BISSN%5D | |||||||||||||||||||||||||||||||||
平均审稿速度 | 网友分享经验: >12周,或约稿 | |||||||||||||||||||||||||||||||||
平均录用比例 | 网友分享经验: 较易 | |||||||||||||||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Current Neuropharmacology顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 | |||||||||||||||||||||||||||||||||
期刊常用信息链接 |
|
|
|
中国学者近期发表的论文 | |
1. | Comparative Analysis of the Pre- and Post-Medication Effects of Antipsychotic Agents on the Blood-Based Oxidative Stress Biomarkers in Patients with Schizophrenia: A Meta-Analysis Author: Yang, Mi; Wang, Chunzhi; Zhao, Guocheng; Kong, Di; Liu, Liju; Yuan, Shuai; Chen, Wei; Feng, Can; Li, Zezhi Journal: CURRENT NEUROPHARMACOLOGY. 2023; Vol. 21, Issue 2, pp. 340-352. DOI: 10.2174/1570159X20666220706101021 PubMed DOI |
2. | New Insights of Early Brain Injury after Subarachnoid Hemorrhage: A Focus on the Caspase Family Author: Wang, Xiaoyu; Xu, Penglei; Liu, Yibo; Wang, Zefeng; Lenahan, Cameron; Fang, Yuanjian; Lu, Jianan; Zheng, Jingwei; Wang, Kaikai; Wang, Wei; Zhou, Jingyi; Chen, Sheng; Zhang, Jianming Journal: CURRENT NEUROPHARMACOLOGY. 2023; Vol. 21, Issue 2, pp. 392-408. DOI: 10.2174/1570159X20666220420115925 PubMed DOI |
3. | Early Efficacy of Antipsychotic Medications at Week 2 Predicts Subsequent Responses at Week 6 in a Large-scale Randomized Controlled Trial Author: Tang, Yiguo; Wu, Yulu; Li, Xiaojing; Hao, QinJian; Deng, Wei; Yue, Weihua; Yan, Hao; Zhang, Yamin; Tan, Liwen; Chen, Qi; Yang, Guigang; Lu, Tianlan; Wang, Lifang; Yang, Fude; Zhang, Fuquan; Yang, Jianli; Li, Keqing; Lv, Luxian; Tan, Qingrong; Zhang, Hongyan; Ma, Xin; Li, Lingjiang; Wang, Chuanyue; Ma, Xiaohong; Zhang, Dai; Yu, Hao; Zhao, Liansheng; Ren, Hongyan; Wang, Yingcheng; Zhang, Guangya; Li, Chuanwei; Du, Xiangdong; Hu, Xun; Li, Tao; Wang, Qiang Journal: CURRENT NEUROPHARMACOLOGY. 2023; Vol. 21, Issue 2, pp. 424-436. DOI: 10.2174/1570159X21666221118164612 PubMed DOI |
4. | Effect of Repetitive Transcranial Magnetic Stimulation in Inducing Weight Loss in Patients with Chronic Schizophrenia: A Randomized, Double-Blind Controlled 4-Week Study Author: Su, Xiuru; Wang, Xuan; Pan, Xiuling; Zhang, Xuan; Lu, Xinyan; Zhao, Long; Chen, Yingnan; Shang, Yujie; Zhu, Lin; Lu, Shulan; Zhu, Xiaolin; Wu, Fengchun; Xiu, Meihong Journal: CURRENT NEUROPHARMACOLOGY. 2023; Vol. 21, Issue 2, pp. 417-423. DOI: 10.2174/1570159X20666220524123315 PubMed DOI |
5. | Neuronavigated Repetitive Transcranial Stimulation Improves Neurocognitive Functioning in Veterans with Schizophrenia: A Possible Role of BDNF Polymorphism Author: Su, Xiuru; Liu, Haixia; Wang, Xuan; Pan, Xiuling; Zhang, Xuan; Lu, Xinyan; Zhao, Long; Chen, Yingnan; Shang, Yujie; Wu, Fengchun; Xiu, Meihong Journal: CURRENT NEUROPHARMACOLOGY. 2023; Vol. 21, Issue 1, pp. 142-150. DOI: 10.2174/1570159X20666220803154820 PubMed DOI |
6. | Energy Crisis Links to Autophagy and Ferroptosis in Alzheimer's Disease: Current Evidence and Future Avenues Author: He, Da-Long; Fan, Yong-Gang; Wang, Zhan-You Journal: CURRENT NEUROPHARMACOLOGY. 2023; Vol. 21, Issue 1, pp. 67-86. DOI: 10.2174/1570159X20666220817140737 PubMed DOI |
7. | Epilepsy and Autism Spectrum Disorder (ASD): The Underlying Mechanisms and Therapy Targets Related to Adenosine Author: Guo, Mengyi; Xie, Pandeng; Liu, Siqi; Luan, Guoming; Li, Tianfu Journal: CURRENT NEUROPHARMACOLOGY. 2023; Vol. 21, Issue 1, pp. 54-66. DOI: 10.2174/1570159X20666220706100136 PubMed DOI |
8. | Prevention and Treatment for Chemotherapy-Induced Peripheral Neuropathy: Therapies Based on CIPN Mechanisms. Author: Hu LY1, Mi WL1, Wu GC1, Wang YQ1, Mao-Ying QL1. Journal: Curr Neuropharmacol. 2019;17(2):184-196. doi: 10.2174/1570159X15666170915143217. PubMed DOI |
9. | The Role of CXCR3 in Neurological Diseases. Author: Zhou YQ1,2, Liu DQ1,2, Chen SP1,2, Sun J1,2, Zhou XR3, Xing C4, Ye DW3, Tian YK1,2. Journal: Curr Neuropharmacol. 2019;17(2):142-150. doi: 10.2174/1570159X15666171109161140. PubMed DOI |
10. | Targeting Cytokines for Morphine Tolerance: A Narrative Review. Author: Liu DQ1,2, Zhou YQ1,2, Gao F1,2. Journal: Curr Neuropharmacol. 2019;17(4):366-376. doi: 10.2174/1570159X15666171128144441. PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室